Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $523.00M | $606.00M | $2.69B | $720.00M | $684.00M |
| Total Operating Revenue | $523.00M | $606.00M | $2.69B | $720.00M | $684.00M |
| Cost of Revenue | $367.00M | $476.00M | $2.05B | $540.00M | $518.00M |
| Gross Profit | $156.00M | $130.00M | $634.00M | $180.00M | $166.00M |
| Operating Expense | $142.00M | $149.00M | $608.00M | $163.00M | $151.00M |
| Selling and Admin Expenses | $112.00M | $110.00M | $453.00M | $120.00M | $111.00M |
| Research & Development | $30.00M | $39.00M | $155.00M | $43.00M | $40.00M |
| Operating Profit | $14.00M | -$19.00M | $26.00M | $17.00M | $15.00M |
| Net Non-Operating Interest Income (Expense) | -$15.00M | -$16.00M | -$56.00M | -$16.00M | -$16.00M |
| Non-Operating Interest Income | $1.00M | $0.00 | $8.00M | $1.00M | $0.00 |
| Non-Operating Interest Expense | $15.00M | $15.00M | $60.00M | $16.00M | $15.00M |
| Total Other Finance Costs | $1.00M | $1.00M | $4.00M | $1.00M | $1.00M |
| Other Income (Expense) | -$1.00M | -$6.00M | -$1.00M | $21.00M | -$22.00M |
| Gain on Sale of Security | -$1.00M | – | -$3.00M | -$1.00M | -$1.00M |
| Pretax Profit | -$2.00M | -$41.00M | -$31.00M | $22.00M | -$23.00M |
| Tax | -$1.00M | -$39.00M | -$73.00M | -$56.00M | -$6.00M |
| Net Profit | $2.00M | -$5.00M | $62.00M | $98.00M | -$19.00M |
| Profit from Continuing Operations | -$1.00M | -$2.00M | $42.00M | $78.00M | -$17.00M |
| Net Income from Discontinuous Operations | $3.00M | -$3.00M | $20.00M | $20.00M | -$2.00M |
| Minority Interests | $0.00 | – | $0.00 | $0.00 | $0.00 |
| Net Income to Parent Company | $2.00M | -$5.00M | $62.00M | $98.00M | -$19.00M |
| Preferred Stock Dividends | $3.00M | $3.00M | $20.00M | $9.00M | $3.00M |
| Net Income to Common Stockholders | -$1.00M | -$8.00M | $42.00M | $89.00M | -$22.00M |
| Basic EPS | -$0.01 | -$0.06 | $0.30 | $0.64 | -$0.16 |
| Diluted EPS | -$0.01 | -$0.06 | $0.30 | $0.63 | -$0.16 |
| Other Non-Operating Income (Expenses) | – | -$6.00M | $2.00M | $22.00M | -$21.00M |
| Special Income (Charges) | – | – | $0.00 | $0.00 | $0.00 |
| -General & Admin Expense | – | – | – | – | $111.00M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $3.85B | $3.92B | $3.92B | $3.92B | $4.00B |
| Total Current Assets | $1.12B | $1.17B | $1.10B | $1.10B | $1.26B |
| Cash and Cash Equivalents & Short-Term Investments | $237.00M | $232.00M | $231.00M | $231.00M | $282.00M |
| -Cash and Cash Equivalents | $237.00M | $232.00M | $231.00M | $231.00M | $282.00M |
| Receivables | $452.00M | $457.00M | $470.00M | $470.00M | $548.00M |
| -Accounts Receivable | $472.00M | $476.00M | $491.00M | $491.00M | $517.00M |
| -Receivables Adjustments Allowances | -$20.00M | -$19.00M | -$21.00M | -$21.00M | -$21.00M |
| Inventory | $128.00M | $159.00M | $217.00M | $217.00M | $221.00M |
| Restricted Cash | $14.00M | $11.00M | $8.00M | $8.00M | $6.00M |
| Other Current Assets | $286.00M | $314.00M | $177.00M | $177.00M | $206.00M |
| Total Non-Current Assets | $2.73B | $2.75B | $2.82B | $2.82B | $2.74B |
| Net PPE | $366.00M | $375.00M | $382.00M | $382.00M | $381.00M |
| -Gross PPE | $366.00M | $375.00M | $1.02B | $1.02B | $381.00M |
| Goodwill and Other Intangible Assets | $1.59B | $1.60B | $1.60B | $1.60B | $1.61B |
| -Goodwill | $1.52B | $1.52B | $1.52B | $1.52B | $1.52B |
| -Other Intangible Assets | $70.00M | $76.00M | $83.00M | $83.00M | $90.00M |
| Defined Pension Benefit | $49.00M | $49.00M | $50.00M | $50.00M | $51.00M |
| Non-Current Deferred Assets | $195.00M | $195.00M | $185.00M | $185.00M | $183.00M |
| Other Non-Current Assets | $535.00M | $535.00M | $598.00M | $598.00M | $515.00M |
| Total Liabilities | $2.72B | $2.79B | $2.77B | $2.77B | $2.88B |
| Total Current Liabilities | $1.04B | $1.11B | $1.07B | $1.07B | $1.11B |
| Payables | $411.00M | $371.00M | $346.00M | $346.00M | $375.00M |
| -Accounts Payable | $411.00M | $371.00M | $346.00M | $346.00M | $375.00M |
| Current Accrued Expenses | $95.00M | $95.00M | $98.00M | $98.00M | $99.00M |
| Current Deferred Liabilities | $184.00M | $223.00M | $202.00M | $202.00M | $207.00M |
| Other Current Liabilities | $353.00M | $418.00M | $419.00M | $419.00M | $432.00M |
| Total Non-Current Liabilities | $1.68B | $1.68B | $1.70B | $1.70B | $1.77B |
| Long Term Accounts Payable and Other Payables | $49.00M | $46.00M | $51.00M | $51.00M | $53.00M |
| Long Term Debt and Capital Lease Obligation | $1.31B | $1.32B | $1.33B | $1.33B | $1.33B |
| -Long Term Debt | $1.10B | $1.10B | $1.10B | $1.10B | $1.10B |
| -Long Term Capital Lease Obligation | $211.00M | $219.00M | $226.00M | $226.00M | $232.00M |
| Employee Benefits | $169.00M | $167.00M | $168.00M | $168.00M | $207.00M |
| Other Non-Current Liabilities | $146.00M | $146.00M | $156.00M | $156.00M | $175.00M |
| Total Equity | $1.13B | $1.14B | $1.16B | $1.16B | $1.12B |
| Stockholders' Equity | $1.13B | $1.14B | $1.16B | $1.16B | $1.12B |
| Capital Stock | $208.00M | $208.00M | $208.00M | $208.00M | $277.00M |
| -Common Stock | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M |
| -Preferred Stock | $207.00M | $207.00M | $207.00M | $207.00M | $276.00M |
| Additional Paid-In Capital | $826.00M | $824.00M | $827.00M | $827.00M | $823.00M |
| Retained Earnings | $550.00M | $551.00M | $559.00M | $559.00M | $470.00M |
| Gains/Losses Not Affecting Retained Earnings | -$451.00M | -$448.00M | -$439.00M | -$439.00M | -$446.00M |
| Minority Interests | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Accumulated Depreciation | – | – | -$633.00M | -$633.00M | – |
| -Other Receivables | – | – | – | – | $52.00M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $17.00M | $42.00M | -$210.00M | $60.00M | $14.00M |
| Net cash flow from continuing operations | $17.00M | $42.00M | -$210.00M | $60.00M | $14.00M |
| Net Income from Continuing Operations | $2.00M | -$5.00M | $62.00M | $98.00M | -$19.00M |
| Gain/Loss from Continuing Operations | $0.00 | $9.00M | -$22.00M | -$17.00M | – |
| Depreciation & Depletion & Amortization | $53.00M | $53.00M | $231.00M | $58.00M | $55.00M |
| Deferred Tax | $0.00 | -$10.00M | $9.00M | -$1.00M | $10.00M |
| Change in Working Capital | -$52.00M | -$14.00M | -$526.00M | -$88.00M | -$35.00M |
| -Change in Receivables | $5.00M | $15.00M | $54.00M | $78.00M | -$41.00M |
| -Change in Inventory | $5.00M | -$47.00M | -$26.00M | $0.00 | -$11.00M |
| -Change in Payables and Accrued Expense | $44.00M | $21.00M | -$15.00M | -$28.00M | $34.00M |
| -Change In Other Working Capital | -$106.00M | -$3.00M | -$539.00M | -$138.00M | -$17.00M |
| Net cash flow from investing | $12.00M | -$21.00M | -$134.00M | -$24.00M | -$35.00M |
| Net Cash Flow from Continuing Investing Activities | $12.00M | -$21.00M | -$134.00M | -$24.00M | -$35.00M |
| Capital Expenditure | -$41.00M | -$36.00M | -$165.00M | -$46.00M | -$38.00M |
| Net Other Investing Changes | $50.00M | $18.00M | $8.00M | $0.00 | $2.00M |
| Financing Cash Flow | -$21.00M | -$18.00M | -$175.00M | -$85.00M | -$4.00M |
| Net Cash Flow from Continuing Financing Activities | -$21.00M | -$18.00M | -$175.00M | -$85.00M | -$4.00M |
| Net Issuance Payments Of Debt | -$9.00M | -$4.00M | -$13.00M | -$3.00M | -$3.00M |
| Net Common Stock Issuance | -$11.00M | -$9.00M | -$148.00M | -$79.00M | $0.00 |
| Cash Dividends Paid | -$3.00M | -$3.00M | -$15.00M | -$4.00M | -$3.00M |
| Proceeds from Stock Option Exercised | $3.00M | $2.00M | $10.00M | $3.00M | $2.00M |
| Net Other Financing Charges | -$1.00M | -$4.00M | -$9.00M | -$2.00M | $0.00 |
| Ending Cash Balance | $254.00M | $246.00M | $243.00M | $243.00M | $292.00M |
| Net Change in Cash | $8.00M | $3.00M | -$519.00M | -$49.00M | -$25.00M |
| Beginning Cash Balance | $246.00M | $243.00M | $758.00M | $292.00M | $318.00M |
| Effect of Exchange Rate Changes | $0.00 | $0.00 | $4.00M | $0.00 | -$1.00M |
| Free Cash Flow | -$21.00M | $3.00M | -$375.00M | $17.00M | -$27.00M |
| Net Intangibles Purchase and Sale | – | -$3.00M | $3.00M | $6.00M | – |
| Net PPE Purchase and Sale | – | – | $16.00M | – | – |
| Net Business Purchase and Sale | – | – | $4.00M | $0.00 | – |
| Net Investment Purchase and Sale | – | – | $0.00 | – | – |
No comments yet — be the first to weigh in on VYX.